Accreditation
Language
English
We offer our registered users tailored information, free online courses and exclusive content.
English
Epidemiological studies and the availability of new technologies for diagnosing and treating multiple sclerosis (MS) have dramatically changed the management of the disease all over the world and in the Middle East. Therefore, there is an increasing need for continuous education about all aspects of MS management, from diagnosis to treatment. This workshop will update and share knowledge about these critical topics of multiple sclerosis, focusing on disease staging and on the risk/benefit profile of lifelong treatments.
• Illustrate MS diagnostic criteria and the key elements of differential diagnosis
• Explain treatment algorithms according to individual prognosis
• Describe risk/benefit profile of maintenance treatment and PIRT
• Illustrate how to manage cognitive impairment in the clinical setting
The CME “multiple sclerosis management: the value of experience a pre-MENACTRIMS workshop” held on 23 November 2017 in Dubai, UAE is designated for a maximum of 6 (six)
hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized
by the American Medical Association (AMA) towards the Physician’s Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.
08.45 Introduction and welcome
J. Inshasi (UAE) - B. Yamout (Lebanon)
09.00 L1: Risk factors for MS: genes, environment, diet, urbanization VIDEO LECTURE
M. Ali Sahraian (Iran)
09.30 L2: Update on diagnostic criteria and differential diagnosis VIDEO LECTURE
B. Yamout (Lebanon)
10.00 L3: Clinical and MRI prognostic factors at onset and during treatment
N. De Stefano (Italy)
10.30 Coffee break
11.00 L4: Treatment goals and unmet needs in MS today VIDEO LECTURE
M. Freedman (Canada)
11.30 L5: Individualised treatment in MS: efficacy of maintenance therapy and pirT
N. Grigoriadis (Greece)
12.00 L6: Individualised treatment in MS: safety of maintenance therapy and pirT VIDEO LECTURE
P. Vermersch (France)
12.30 Discussion
13.00 Lunch
14.15 L7: Burden of treatment and health related quality of life VIDEO LECTURE
P. Rieckmann (Germany)
14.45 L8: Pharmacological and non pharmacological approach to cognitive impairment VIDEO LECTURE
M.P. Amato (Italy)
15.15 Interactive clinical cases session
S. Schippling (Switzerland)
16.15 Panel discussion
16.45 Concluding remarks
End of the workshop